|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -0.79% |
|
+7.69% | -45.92% |
| 07-27 | Spero Therapeutics, Inc. Announces Appointment of Debra Jeske Zack as Chief Medical Officer | CI |
| 07-15 | Innovent Biologics Shares Surge on Spero Deal That Could Be Worth $1.1 Billion | DJ |
| Market Cap | 72.96M 63.11M 58.93M 54.06M 102M 6.94B 103M 691M 271M 3.48B 274M 268M 11.51B | P/E 2024 |
-0.81x | P/E 2025 | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 72.96M 63.11M 58.93M 54.06M 102M 6.94B 103M 691M 271M 3.48B 274M 268M 11.51B | EV / Sales 2024 |
1,170,430x | EV / Sales 2025 | - |
| Free-Float |
77.49% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Spero Therapeutics, Inc.
| 1 day | -0.79% | ||
| 1 week | +7.69% | ||
| Current month | +7.69% | ||
| 1 month | -41.94% | ||
| 3 months | -50.78% | ||
| 6 months | -47.93% | ||
| Current year | -45.92% |
| 1 week | 1.12 |  | 1.28 |
| 1 month | 1.08 | | 2.34 |
| Current year | 1.08 | | 3.08 |
| 1 year | 1.08 | | 3.08 |
| 3 years | 0.51 | | 3.22 |
| 5 years | 0.51 | | 19.87 |
| 10 years | 0.51 | | 23.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Esther Rajavelu
CEO | Chief Executive Officer | 47 | 10/01/2025 |
Debra Zack
CTO | Chief Tech/Sci/R&D Officer | 69 | 27/07/2026 |
Timothy Keutzer
COO | Chief Operating Officer | 58 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Milind Deshpande
CHM | Chairman | 69 | 01/01/2014 |
| Director/Board Member | 62 | 01/09/2015 | |
Frank Thomas
CHM | Chairman | 56 | 10/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/3/26 A | Free | Chief Technology Officer | 486,986 | 0.8411% | ||
| 2/6/26 A | Sell | Chief Executive Officer | 87,917 | 0.1560% | ||
| 2/6/26 A | Sell | Chief Operating Officer | 18,652 | 0.0331% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | +7.69% | -42.47% | -14.86% | 72.96M | |
| +8.49% | +20.55% | +70.77% | +110.32% | 68.12B | |
| +1.25% | +2.44% | +34.27% | +70.43% | 55.18B | |
| -1.09% | +32.96% | +19.67% | +494.56% | 28.63B | |
| +10.83% | +18.38% | +56.20% | +6.03% | 23.99B | |
| +2.72% | +3.41% | -16.11% | -7.96% | 23.53B | |
| +6.50% | +7.56% | +44.65% | -21.73% | 18.45B | |
| +6.20% | +11.51% | +33.87% | +693.38% | 16.44B | |
| -3.88% | +16.98% | +199.30% | +359.77% | 15.83B | |
| +3.58% | +1.96% | +43.35% | +163.76% | 13.4B | |
| Average | +3.38% | +11.28% | +44.35% | +185.37% | 26.36B | |
| Weighted average by Cap. | +4.36% | +13.09% | +50.66% | +168.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 47.98M 41.5M 38.75M 35.55M 66.87M 4.57B 67.93M 455M 178M 2.29B 180M 176M 7.57B | 66.8M 57.78M 53.96M 49.5M 93.11M 6.36B 94.58M 633M 248M 3.19B 251M 245M 10.53B |
| Net income | -68.57M -59.31M -55.39M -50.81M -95.56M -6.53B -97.08M -650M -255M -3.27B -257M -252M -10.81B | 8.57M 7.41M 6.92M 6.35M 11.95M 816M 12.14M 81.24M 31.89M 409M 32.19M 31.48M 1.35B |
| Net Debt | - | - |
Employees
25
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | $1.260 | -0.79% | 459,025 |
| 06/08/26 | $1.270 | +0.79% | 974,681 |
| 05/08/26 | $1.260 | +2.44% | 574,907 |
| 04/08/26 | $1.230 | +6.96% | 752,105 |
| 03/08/26 | $1.150 | -1.71% | 1,373,121 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.260USD
Average target price
4.000USD
Spread / Average Target
+217.46%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
Select your edition
All financial news and data tailored to specific country editions
